Form 4: Elanco Animal Health Exec Trades Shares

Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc., reported a transaction involving deferred stock units.

Summary

• Jeffrey N. Simmons, who holds the positions of President, CEO, and Director at Elanco Animal Health Inc., has reported a transaction.
• The transaction involved deferred stock units, with each unit representing the right to receive one share of Company common stock or its cash equivalent.
• The earliest transaction date noted is June 26, 2026.
• A total of 115.0562 deferred stock units were acquired, with a settlement value of $24.57 per unit.
• These units are expected to settle in cash or shares of Company common stock following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine executive transaction related to compensation rather than a significant strategic event or performance indicator.

Positives

• The reporting person, a key executive and director, is actively participating in the company's equity plans.
• The transaction indicates continued engagement with the company's stock through deferred units.

Risks

• The value of the deferred stock units is subject to fluctuations in Elanco Animal Health Inc.'s common stock price.
• Settlement of these units is contingent upon future events such as termination of employment or a specified future year.

Future Outlook

The future outlook for the deferred stock units depends on the company's stock performance and the executive's employment status or chosen settlement year.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for tracking insider transactions, providing transparency into executive compensation and potential stock ownership changes within the animal health sector.

Stakeholder Impact

• Shareholders: Provides insight into executive compensation and potential future share dilution or acquisition.
• Employees: Reflects the company's use of equity-based compensation for its leadership.
• Management: Confirms continued participation in company equity plans.

Next Steps

• Settlement of deferred stock units according to the Executive Deferral and Stock Match Plan.

Key Dates

Keywords

Elanco Animal Health, ELAN, Form 4, Insider Trading, Deferred Stock Units, Executive Compensation, Securities Transaction